CamPath.com provides resources for for B-cell chronic lymphocytic leukemia
Title
CamPath® (Alemtuzumab) For Injection - fludarabine refractory B-CLL
Description
Information about Campath®, a treatment for B-cell chronic lymphocytic leukemia (B-CLL) in patients who have been treated with alkylating agents and who have failed fludarabine therapy.
Contact
- Genzyme Corporation
- Framingham MA
- United States 01701
- +1.5082702184